Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.

Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.

Item
http://www.wikidata.org/entity/Q34836622
Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies.Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical management.When to resect following neoadjuvant therapy for esophageal cancer-issues and limitations in addressing this decisionNeoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes.Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes.Effect of neoadjuvant chemoradiotherapy on perioperative immune function of patients with locally advanced esophageal cancer.Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis.Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery.Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy.Clinical predictors of pathologically response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma: long term outcomes of a phase II study
P2860

Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.

Item
http://www.wikidata.org/entity/Q34836622
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Increased time from neoadjuvan ...... se rates in esophageal cancer.
@ast
Increased time from neoadjuvan ...... se rates in esophageal cancer.
@en
Increased time from neoadjuvan ...... se rates in esophageal cancer.
@nl
type
label
Increased time from neoadjuvan ...... se rates in esophageal cancer.
@ast
Increased time from neoadjuvan ...... se rates in esophageal cancer.
@en
Increased time from neoadjuvan ...... se rates in esophageal cancer.
@nl
prefLabel
Increased time from neoadjuvan ...... se rates in esophageal cancer.
@ast
Increased time from neoadjuvan ...... se rates in esophageal cancer.
@en
Increased time from neoadjuvan ...... se rates in esophageal cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Increased time from neoadjuvan ...... se rates in esophageal cancer.
@en
P2093
P2860
P304
P31
P356
10.1016/J.ATHORACSUR.2014.08.033
P407
P433
P478
P577
P698
P921
P932